source
- Novo falls behind Eli Lilly in market race as investors react to Q3 resultsA year ago the competition between Eli Lilly and Novo was described as the fiercest in the industry. Recent commentary suggests the rivalry has become increasingly one‑sided, with Novo struggling t…
- Democratic doctors and scientists win key Senate and gubernatorial races, boosting health policy influenceDemocratic candidates with medical and scientific backgrounds secured several high‑profile victories in the recent midterm elections, contributing to the party’s regain of congressional control. A…